Ibrutinib combination therapy in CLL: overview of the data so far
The rise of MRD in multiple myeloma: could this be an answer to a cure?
Overview of the RATIFY study: midostaurin combination therapy for AML
An introduction into the PATHEMA trial
Novel ALL treatment strategies: blinatumomab